Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Cantor Fitzgerald
US Army
Daiichi Sankyo
McKinsey
Chinese Patent Office
Fuji
Federal Trade Commission

Generated: November 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062638

« Back to Dashboard

NDA 062638 describes ERYTHROCIN, which is a drug marketed by Abbott, Hospira, and Arbor Pharms Llc, and is included in five NDAs. It is available from one supplier. Additional details are available on the ERYTHROCIN profile page.

The generic ingredient in ERYTHROCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 062638
Tradename:ERYTHROCIN
Applicant:Hospira
Ingredient:erythromycin lactobionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 062638
Ingredient-typeMacrolides
Physiological EffectDecreased Sebaceous Gland Activity
Suppliers and Packaging for NDA: 062638
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 062638 ANDA Hospira, Inc. 0409-6476 0409-6476-44 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-6476-44) > 100 mL in 1 VIAL, PATENT DELIVERY SYSTEM (0409-6476-54)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Oct 31, 1986TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Oct 31, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Colorcon
UBS
Federal Trade Commission
Boehringer Ingelheim
Dow
AstraZeneca
McKinsey
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.